Expression of a novel factor, com1, in early tumor progression of breast cancer (2000)
- Authors:
- Autor USP: BRENTANI, MARIA MITZI - FM
- Unidade: FM
- Subjects: ONCOLOGIA; NEOPLASIAS
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2000
- Source:
- Título: Clinical Cancer Research
- ISSN: 1978-0432
- Volume/Número/Paginação/Ano: v. 6, n. 5, p. 1778-1783, May, 2000
-
ABNT
REE, Anne Hansen et al. Expression of a novel factor, com1, in early tumor progression of breast cancer. Clinical Cancer Research, v. 6, n. 5, p. 1778-1783, 2000Tradução . . Acesso em: 12 jan. 2026. -
APA
Ree, A. H., Pacheco, M. M., Tvermyr, M., Fodstad, O., & Brentani, M. M. (2000). Expression of a novel factor, com1, in early tumor progression of breast cancer. Clinical Cancer Research, 6( 5), 1778-1783. -
NLM
Ree AH, Pacheco MM, Tvermyr M, Fodstad O, Brentani MM. Expression of a novel factor, com1, in early tumor progression of breast cancer. Clinical Cancer Research. 2000 ; 6( 5): 1778-1783.[citado 2026 jan. 12 ] -
Vancouver
Ree AH, Pacheco MM, Tvermyr M, Fodstad O, Brentani MM. Expression of a novel factor, com1, in early tumor progression of breast cancer. Clinical Cancer Research. 2000 ; 6( 5): 1778-1783.[citado 2026 jan. 12 ] - Nutriçao e câncer de mama
- Avaliação histológica da cicatrização cutânea de ratos desnutridos após realimentação com dieta enteral especializada
- A transcriptional sketch of breast cancer fibrosblasts: a preliminary study for a high-throughput technology for eDNA sequencing
- Perfil dos hormônios da tireoide em pacientes com câncer de mama em estado de menopausa
- Claudin 4 and 7 Expression Is Not Correlated to Triple Negative Phenotype in Invasive NOS Breast Carcinomas: A Wide Series Assessed by Immunohistochemistry
- Prognostic significance of the combined expression of matrix metalloproteinase-9, urokinase type plasminogen activator and its receptor in breast cancer as measured by Northern blot analysis
- Active specific immunotherapiy using attenuated autologous tumor cells in malignant melanoma
- Triiodotironina ('T IND. 3') mimetiza a ação do estrógeno ('E IND. 2') no cãncer de mama
- Mecanismos de controle para a ativação dos oncogens C-FOS e C-MYC pelo estrógeno ('E IND. 2') e triiodotironina ('T IND. 3') nas células de câncer de mama
- T3 effects are mediated through interaction with estrogen receptor in breast cancer despite the presence of T3 receptors
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
